Drug Development

Clinical Trials Weight Loss Drugs Clinical Research Alzheimer's Disease Injectable Medications Market Trends Oncology Drugs Market Competition COVID-19 Vaccines Obesity Drugs

3 ARTICLES

last wk.

AbbVie to Acquire Capstan Therapeutics for $2.1 Billion to Boost In Vivo CAR-T Portfolio

Pending Hart-Scott-Rodino approval, AbbVie will integrate Capstan’s Phase 1 CAR-T candidate with its targeted lipid nanoparticle platform for precise RNA delivery.

3 ARTICLES

2w ago

AI test identifies which prostate cancer patients could halve their death risk with abiraterone

4 ARTICLES

last mo.

Mixed Phase 3 Outcomes Cloud Future of Regeneron and Sanofi’s COPD Candidate Itepekimab

5 ARTICLES

last mo.

Oral HIV Drug Lamivudine Improves Vision in Diabetic Macular Edema Trial

5 ARTICLES

last mo.

GSK Acquires Experimental Liver Drug Efimosfermin for $1.2 Billion Upfront

8 ARTICLES

2mo ago

Eli Lilly Reports Record Q1 Revenue but Faces Profit Pressure and Competitive Challenges

6 ARTICLES

2mo ago

Australia Subsidizes Esketamine Spray for Treatment-Resistant Depression

6 ARTICLES

2mo ago

Merck KGaA Confirms $3.9 Billion Acquisition of SpringWorks Therapeutics

3 ARTICLES

2mo ago

AI Reveals PHGDH as Key Driver in Spontaneous Alzheimer’s, Paving Way for New Treatment

4 ARTICLES

2mo ago

German Scientists Unveil Breakthrough Malaria Inhibitor Targeting All Parasite Stages

3 ARTICLES

2mo ago

Gilead Sciences Posts Q1 EPS Beat but Revenue Falls Short Amid Mixed Product Performance

4 ARTICLES

2mo ago

Pharmaceutical Giants Grapple With Tariff Uncertainty as Roche Seeks Exemptions

3 ARTICLES

2mo ago

Merck Lowers 2025 Profit Forecast as Tariffs and Licensing Costs Weigh

4 ARTICLES

2mo ago

Roche Announces $50 Billion U.S. Investment to Expand R&D and Manufacturing

3 ARTICLES

3mo ago

Novartis Confirms $23 Billion U.S. Investment with Major Expansion Plans

3 ARTICLES

3mo ago

Novartis Announces $23 Billion U.S. Expansion with New Plants and R&D Hub

Particle.news

Drug Development

AbbVie to Acquire Capstan Therapeutics for $2.1 Billion to Boost In Vivo CAR-T Portfolio

FDA Approves Six-Month HIV Prevention Injection Lenacapavir

FDA Approves Yeztugo, Twice-Yearly HIV Prevention Injection

FDA Approves Twice-Yearly Lenacapavir Injection for HIV Prevention

Eli Lilly to Acquire Verve Therapeutics for $1.3 Billion

AI test identifies which prostate cancer patients could halve their death risk with abiraterone

Mixed Phase 3 Outcomes Cloud Future of Regeneron and Sanofi’s COPD Candidate Itepekimab

Oral HIV Drug Lamivudine Improves Vision in Diabetic Macular Edema Trial

GSK Acquires Experimental Liver Drug Efimosfermin for $1.2 Billion Upfront

Eli Lilly Reports Record Q1 Revenue but Faces Profit Pressure and Competitive Challenges

Never miss stories about

Drug Development

Australia Subsidizes Esketamine Spray for Treatment-Resistant Depression

Merck KGaA Confirms $3.9 Billion Acquisition of SpringWorks Therapeutics

AI Reveals PHGDH as Key Driver in Spontaneous Alzheimer’s, Paving Way for New Treatment

German Scientists Unveil Breakthrough Malaria Inhibitor Targeting All Parasite Stages

Gilead Sciences Posts Q1 EPS Beat but Revenue Falls Short Amid Mixed Product Performance

Pharmaceutical Giants Grapple With Tariff Uncertainty as Roche Seeks Exemptions

Merck Lowers 2025 Profit Forecast as Tariffs and Licensing Costs Weigh

Roche Announces $50 Billion U.S. Investment to Expand R&D and Manufacturing

Novartis Confirms $23 Billion U.S. Investment with Major Expansion Plans

Novartis Announces $23 Billion U.S. Expansion with New Plants and R&D Hub

Never miss stories about

Drug Development